Advertisement

---

ROSETTA GENOMICS LTD.

Medicare Administrator Issues Final Local Coverage Determination for Rosetta Cancer Origin Test™

[2013-06-13] - microRNA assay determined reasonable and necessary for providing an important niche in pathologic diagnoses of Cancer of Unknown Primary


Rosetta Genomics Executes Credentialing Agreement with Three Rivers Provider Network

[2013-06-07] - Preferred Provider Organization network has more than 10 million covered lives; one-in-five Americans now covered for the Rosetta Cancer Origin Test™


Rosetta Genomics Announces Acceptance for Publication by Molecular Cancer of Rosetta Cancer Origin Test Manuscript

[2013-06-06] - Fifth Validation Study Demonstrating Ability to Identify Tumor Origin in Patients with Cancer of Unknown or Uncertain Primary Shows 92% Accuracy, Highest Published Level to Date


Rosetta Genomics to Increase the Number of U.S. Sales Territories

[2013-06-04] - Launches new corporate and product branding at ASCO 2013, reports strong attendance at Industry Expert Theater Presentation


Rosetta Genomics Announces Presence at ASCO 2013

[2013-05-28] - Innovative microRNA based diagnostic test services to be showcased at Exhibit Booth 2101 and featured at an Industry Expert Theater Presentation


Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference

[2013-05-22] -


Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2

[2013-05-20] - Preferred Provider Organization network has more than 6.5 million covered lives


Rosetta Genomics Receives Full Settlement Payment from Sanra Laboratories

[2013-05-10] -


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers